These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure. Mikulic E; Cohn JN; Franciosa JA Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377 [TBL] [Abstract][Full Text] [Related]
27. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Pierpont GL; Cohn JN; Franciosa JA Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563 [No Abstract] [Full Text] [Related]
28. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective. Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573 [TBL] [Abstract][Full Text] [Related]
29. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure. Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928 [TBL] [Abstract][Full Text] [Related]
30. Relative contribution of inotropic and vasodilator effects to amrinone-induced hemodynamic improvement in congestive heart failure. Konstam MA; Cohen SR; Weiland DS; Martin TT; Das D; Isner JM; Salem DN Am J Cardiol; 1986 Feb; 57(4):242-8. PubMed ID: 3004184 [TBL] [Abstract][Full Text] [Related]
31. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency]. Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285 [TBL] [Abstract][Full Text] [Related]
32. Comparative acute hemodynamic effects of intravenous sodium nitroprusside and MDL-17,043, a new inotropic drug with vasodilator effects, in refractory congestive heart failure. Amin DK; Shah PK; Hulse S; Shellock F Am Heart J; 1985 May; 109(5 Pt 1):1006-12. PubMed ID: 3158182 [TBL] [Abstract][Full Text] [Related]
33. Hemodynamic effects of oral ephedrine given alone or combined with nitroprusside infusion in patients with severe left ventricular failure. Franciosa JA; Cohn JN Am J Cardiol; 1979 Jan; 43(1):79-85. PubMed ID: 758774 [No Abstract] [Full Text] [Related]
34. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs. Packer M; Medina N; Yushak M Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552 [TBL] [Abstract][Full Text] [Related]
35. Combination vasodilator therapy for severe chronic congestive heart failure. Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852 [TBL] [Abstract][Full Text] [Related]
37. Vasodilators in the management of acute heart failure. Elkayam U; Janmohamed M; Habib M; Hatamizadeh P Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484 [TBL] [Abstract][Full Text] [Related]
38. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance. Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013 [TBL] [Abstract][Full Text] [Related]
39. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination. Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877 [TBL] [Abstract][Full Text] [Related]
40. Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect. Subramanyam R; Tandon R; Shrivastava S Eur J Pediatr; 1982 Jul; 138(4):307-10. PubMed ID: 7128637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]